Coughlin Timothy
CIK 0001376043
Director
Filings
20
Latest Jun 3, 2026
Issuers covered
4
Showing
20 of 20
Page 1
Track record
2 of 4 open-market trades scored (50% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -11.6% | -11.6% | -0.1% | -23.0% |
| 90 days | 2 | 50% | -2.6% | -2.6% | +9.0% | -14.3% |
| 180 days | 2 | 50% | -1.0% | -1.0% | +12.0% | -14.1% |
| 365 days | 1 | 100% | +78.2% | +78.2% | +78.2% | +78.2% |
Issuers
Companies where Coughlin Timothy has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 7 | May 21, 2026 |
| LIFE | Atyr Pharma Inc | 7 | May 13, 2026 |
| FATE | Fate Therapeutics Inc | 4 | Jun 11, 2024 |
| ADCT | Adc Therapeutics SA | 2 | Jun 3, 2026 |
All filings
20 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|